Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Getong Tongluo capsules for recovery-stage ischemic stroke with grade 1 essential hypertension
ChiCTR1800016667Phase 4Completed
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- May 2015
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of getong tongluo in ischemic stroke and essential hypertension (3 arms), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoints: Modified Rankin Scale and Barthel Index. Started May 2015; status: completed.
02
Drugs
getong tongluo
03
Conditions
ischemic strokeessential hypertension
Beyond the preview
Go deeper on ChiCTR1800016667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016667.